2. Alzheimer A: Ueber eince eigenartige Erkrankung der Hirrinde. Centralblatt fur Nervenheikunde und Psychiatrie. 1907;30; 177-179.
3.
3. Young AW: Franz Nissl, 1860-1918. Alois Alzheimer, 1864-1915, in Neurological Biographies and Addresses. Foundation Volume, Published for the Staff, to commemorate the Opening of the Montreal Neurological Institute of McGill University, London: Oxford University Press, 1936; 107-113.
7. Torack RM: Historical overview of dementia. The pathologic physiology of dementia. New York: Springer-Vertag, 1978; 1-15.
8.
8. Hinsie LE, Campbell RJ: Psychiatric Dictionary. (Fourth edition) Oxford University Press. 1970: 30-30.
9.
9. Terry RD, Gonatas NK, Weiss M: Ultrastructrual studies in Alzheimer's presenile dementia. Am J Pathol. 1964;44: 269-297.
10.
10. Kidd M: Paired helical filaments in electron microscopy of Alzheimer's disease. Nature. 1963; 197: 192-193.
11.
11. Blessed G, Tomlinson Be, Roth M: The association between quantitative measures of dementia and of senile change in the cerebral gray matter of elderly subjects. Br J Psychiatry. 1968; 114: 797-811.
12.
12. Katzman R: Senile dementia of the Alzheimer type-defining a disease. In: Maddox, GL, Auld E, eds. Proceeding of seminars 1976-1980. Durham, NC: Duke University Council on Aging, 1981:19-40.
13.
13. McMenemey MH: The dementias and progressive Disease of the Basal Ganglia, in blackwood. Greenfield's Neuropathology. ed 2Baltimore: Williams & Wilkins Co., 1963; 520-576.
14.
14. Margolia G: Senile Cerebral Disease: A Critical Survey of Traditional Concepts Based Upon Observations with Newer Technics. Lab Invest. 1959; 8:335-370.
15.
15. Hirano A, Zimmerman HM: Alzheimer's Neurofibrillary Changes: A Topographic Study. Arch Neurol. 1962; 7: 227-242.
16.
16. Tomlinson BF, Blessed G, Roth M: Observations on the Brains of Non-Demented Old People. J. Neurol Sci.1968; 7: 331-356.
17.
17. Brun A: The stractural development of Alzheimer's Disease. Dan Med Bull. 1985;32 (supp 1): 25-25.
18.
18. Ball MJ, Fishman H, et al: Hippocampal morphology in Alzheimer's Dementia:Implication for neurochemical hypothesis. In: R. Katzman ed. Banbury report 15: biological aspect of Alzheimer's Disease. New York:Cold Spring Harbor Laboratory. 1983:45-64.
21. Roth M: Diagnosis of senile dementia and related forms of dementia. Aging. 1978; 7:71-85.
22.
22. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939-944.
32. Corey-Bloom J, Galasko D, Thai L: Clinical features and natural history of Alzheimer's Disease. In: Calne DB (ed). Neuro-degenerative Diseases. Philadelphia: WB Saunders, 1994; 634-634.
33.
33. Chartier Harlin MC, Crawford F, Houlden H, et al: Early onset Alzheimer's disease caused by mutations at codon 717 of the Beta-amyloid precursor protein gene. Nature. 1991;353: 844-846.
34.
34. Goate A, Chartier Harlin MC, Nullan M, et al: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991;349: 704-706.
35.
35. Mullan M, Crawford F, Axelman K, et al: A new mutation in APP demonstrates that pathogenic mutations for probable Alzheimer's disease frame the beta-amyloid sequence. Nature Genetics. 1992; 1: 345-347.
36.
36. Murrel J, Farlow M, Ghetti B, et al: A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science. 1991;254: 97-99.
37.
37. Levy-Lahad E, Wasco W, et al: Candidate Gene for the Chromosome 1 familial Alzheimer's Disease locus. Science. 1995;269: 973-977.
38.
38. Goate Am, Haynes AR, Owen MJ, et al: Predisposing locus for Alzheimer's disease on chromosome 21. Lancet. 1989; 1: 352-355.
39.
39. Pericak-Vance MA, Bebout JL, Gaskell PC, et al: Linkage studies in familial Alzheimer's disease: Evidence for chromosome 19Linkage Am JHum Genet. 1991;48: 1034-1050.
40.
40. Schellenberg GD, Deeb SS, Boehnke M, et al: Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type. Journal of Neurogenetics. 1987;S4: 97-108.
41.
41. Saunders AM, Stritttmater WJ, Sehmechel D, et al: Association of apolipoprotein E allele (e4) with late onset familial and sporadic Alzheimer's disease. Neurology. 1993;43: 1467-1472.
42.
42. Cai XD, Golde TE, Younkin SG: Excess amyloid beta-protein is released from a mutant amyloid beta-protein precursor linked to familial Alzheimer's disease. Science. 259: 514-516, 1993.
43.
43. Citron M, Oltersdorf T, Haass C, et al: Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease causes increased beta-amyloid production. Nature. 360: 672-674, 1992.
44.
44. Selkoe DJ: The molecular pathology of Alzheimer's disease. Neuron. 1991;6: 487-491.
45.
45. Chartier Harlin MC, Crawford F, Hamandi K, et al: Screening for the beta-amyloid precursor protein mutation (APP: Val-lle) in extended pedigrees with early onset Alzheimer's disease. Neuroscience Letters. 1991;129: 134-135.
46.
46. Kamino K, Orr HT, Payami H, et al: Linkage and mutational analysis of familial Alzheimer's disease kindreds for the APP gene region. Am JHum Genet. 1992; 51: 998-1014.
47.
47. Glenner GG, Wong CW: Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloic protein. Biochem Biophys Res Commun. 1984;120: 855-890.
48.
48. Masters CL, Multhaup G, Pottgiesser J, Martins RN, Beyreuther K: Neuronal origin of a cerebral amyloid; neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J.1985;4: 2757-2763.
49.
49. Masters CL, Simms G, Weinman NA, et al: Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA. 1985; 82: 4245-4249.
50.
50. Hardy J, Allsop D: Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends in Pharmacological Sciences. 1991;12: 383-388.
51.
51. Yankner BA, Mesulam MM: (-\Amyloid and the pathogenesis of Alzheimer's Disease. NEJM. December 1991; 325(26): 1849-1857.
52.
52. Schmechel DE, Sanders AM, Stritmatter WJ, et al: Increased amyloid B-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA. 1993;90: 9649-9653.
53.
53. Rebeck GW, Reiter JS, Strickland DK, et al: Apolipoprotein E in sporadic Alzheimer;s disease: allelic variation and receptor interactions. Neuron. 1993; 11: 575-580.
54.
54. Etcheberrigaray R, Ito E, et al: Soluble P-Amyloid induction of Alzheimer's phenotype for human fibroblast K+ Channels. Siense. 1994;264: 276-278.
55.
55. Kang J, Lemaire HG, Unterbeck A, et al: The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface cerebral receptor. Nature. 1987;325: 733-736.
56.
56. Asada T, Yamagata Z, et al: Prevalence of dementia and distribution of ApoE alleles in Japanese Centenarians: An Almost-Complete Survey in Yamanashi Prefecture, Japan. JAGS. 1996; 44(2): 151-155.
57.
57. Stitmatter WJ, Saunders AM, Schmechel D, et al: Apolipoprotein E: high-avidity binding to B-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA. 1993;90: 1977-1981.
58.
58. Saunders AM, Stritmatter WJ, Schmechel D, et al: Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993; 43: 1467-1472.
59.
59. Anwer N, Lovestone S, Cheetham ME, et al: Apolipoprotein E-4 allele and Alzheimer's disease. Lancet. 1993; 342: 1308-1309.
60.
60. Lucotte G, David S, et al: Apolipoprotein E-4 allele and Alzheimer's disease. Lancet. 1993; 342: 111-309.
61.
61. Borgaonkar DS, Schmidt LC, Martin SE, et al: Linkage of lateonset Alzheimer's disease with apolipoprotein E type 4 on chromosome 19. Lancet. 1993; 342: 625-625.
62.
62. Poirier J, Davignon J, Bouthillier D, et al: Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 1993; 342: 697-699.
63.
63. Saunders AM, Schmader K, Breitner JCS, et al: Apolipoprotein E-4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet. 1993: 342: 710-711.
64.
64. Davignon J, Gregg RE, Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988; 8: 1-21.
65.
65. Corder EH, Saunders AM, Strittmatter WJ, et al: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993; 261: 921-923.
66.
66. Houlden H, Crook R, Duff K, et al: Confirmation that the apolipoprotein E, E4 allele is associated with late onset, familial Alzheimer's disease. Neurodegeneration. 1993; 2: 283-286.
67.
67. Strittmatter WJ, Saunders AM, Schmechel D, et al: Apolipoprotein E: High avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer. Proc Natl Acad Sci USA. 1993; 90: 1977-1981.
68.
68. Strittmater WJ, Weisgraber KH, Huanag D, et al: Binding of human apolipoprotein E to beta/A4 peptide. Isoform-specific effects and implications for late onset Alzheimer's disease. Proc Natl Acad Sci USA. 1993;90: 8098-8102.
69.
69. Wisniewski T, Frangione B: Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid. Neuroscience Letters. 1993; 135: 235-239.
70.
70. Polvikoski T, Sulkava R, et al: Apoprotein E, dementia, and cortical deposition of 3-Amyloid protein. NEJM. 1995; 333(19): 1242-1247.
71.
71. Schmechel DE, Saunders AM, Stritmatter WJ, et al: Increased amyloid B-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Peoc Natl Acad Sci USA. 1993; 90: 9649-9653.
72.
72. Wisniewski T, Frangione B: Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett.1992: 135: 235-238.
73.
73. Namba Y, Tomonaga M, Kawasaki H, et al: Apolipoprotein E. immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res.1991; 541: 163-166.
74.
74. Wisniewski T, Golabek A, Matsubara E, et al: Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid. Biochem Biophys Res Commun. 1993; 192: 359-365.
75.
75. Houlden H, Crook R, Duff K, et al: Confirmation that the Apoprotein E, E4, allele is associated with late onset, familial Alzheimer's Disease. Neurodegeneration. 1993; 2: 283-286.
76.
76. Sherrington R, Rogaev El, et al: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995; 376: 754-780.
77.
77. Nullan M, Houlden H, Windelspecht M, et al: A locus for familial early onset Alzheimer's disease on the long arm of chromosome 14 proximal to the alpha 1 antichymotrypsin gene. Nature Genetics. 1992;2: 340-343.
78.
78. St. George Hyslop PH, Haines J, Rogaev E, et al: Genetic evidence for a noval familial Alzheimer's Disease locuse on chromozome 14. Nature Genetics. 1992; 2: 330-334.
79.
79. Weitkamp LR, Nee L, Keats B, et al: Alzheimer disease: Evidence for susceptibility loci on chromosome 6 and 14. Am JHum Genet. 1983;35: 443-453.
80.
80. Schellenberg GD, Bird T, Wijsman E, et al: Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science. 1992;258: 668-671.
81.
81. Van Broeckhoven C, Backhovens H, Cruts M, et al: Mapping of gene predisposing to early onset Alzheimer's disease to chromosome 14q24.3. Nature Genet. 1992; 2: 335-339.
82.
82. Schmechel DE, Saunders AM, Strittmatter WJ, et al: Increased beta-amyloid deposition as a consequence of apolipoprotein E genotype in late onset Alzheimer's disease. Proc Natl Acad Sci USA. 1993, in press.
83.
83. Sherrington El, Liang Y, Rogaeva EA, et al: Cloning of a gene bearing mutations in early-onset familial Alzheimer's disease. Nature. June 1995; 376: 754-760.
84.
84. Levy-Lahad E, Wijsman M, et al: A familial Alzheimer's disease locus on Chromosome 1. Science. 1995; 269: 970-973.
87. Royall DR: Qualitative assessment of dementia. JAM Geriatr Soc.1994;42: 798-799.
88.
88. Crawford F, Hardy J, Mullan M, et al: Sequencing of exons 16 and 17 of the beta-amyloid precursor protein gene in families with early onset Alzheimer's disease fails to reveal mutations in the betaamyloid sequence. Neuroscience Letters. 1991; 133: 1-2.
89.
89. Tanzi RE, Vaula G, Romano D, et al: Assessment of amyloid beta-protein gene mutations in a large set of families and sporadic Alzheimer's disease cases. Am JHum Genet. 1992; 51: 273-282.
90.
90. Van Duijn CM, Hendriks L, Cruts M, et al: Amyloid precursor protein gene mutation in early-onset Alzheimer's disease. Lancet. 1991; 337:978.